文献速递主动脉疾病

高通量中心破裂腹主动脉瘤腔内与开放修复的Q-TWiST及成本效果分析

Q-TWiST and Cost-Effectiveness Analysis of Endovascular versus Open Repair for Ruptured Abdominal Aortic Aneurysms in a High Deliberate Practice Volume Center.
PubMed 文献 · Ann Vasc Surg · 2018-11-23

本研究在单中心对比破裂腹主动脉瘤腔内修复(rEVAR)与开放修复(rOSR)的成本效果,rEVAR常超适应证用于短颈或严重成角病例。3年时rEVAR与rOSR在费用和QALY上无显著差异,但rOSR免于再干预率显著更高。

要点

  • rEVAR与rOSR的3年费用和QALY无显著差异
  • rOSR 3年免于再干预率显著高于rEVAR
  • rEVAR围术期并发症和死亡率数值上更低但无统计学差异

核心结论

  • rEVAR与rOSR在费用或QALY上无显著差异,即使rEVAR用于超适应证的复杂病例。
  • rOSR患者3年免于二次干预率显著高于rEVAR患者。

研究设计与样本

  • 单中心2002至2016年所有破裂腹主动脉瘤修复术的回顾性分析。

主要发现

  • 初次技术成功率rEVAR 89.1% vs rOSR 87.8%(P=0.1),围术期并发症56.5% vs 64.3%(P=0.457),死亡率26.1% vs 28.6%(P=0.794)。
  • 3年免于再干预率rEVAR 74% vs rOSR 90%(P=0.038)。
  • 3年动脉瘤相关生存率rEVAR 65% vs rOSR 62%(P=0.848),全因生存率56% vs 51%(P=0.577)。
  • 3年QALY rEVAR 1.671 vs rOSR 1.549(P=0.502)。
  • 3年rEVAR中位费用€23,352 vs rOSR €20,494(P=0.084),每QALY中位费用€13,974 vs €13,230(P=0.296)。

关键数值与推荐

  • rEVAR vs rOSR的ICER为€23,426(95%CI <€0至>€30,000)。
  • 3年Q-TWiST曲线下面积及95%CI rEVAR 500.819 vs rOSR 437.838。

临床怎么用

  • 在高通量中心,rEVAR可考虑用于解剖复杂(短颈或严重成角)的破裂腹主动脉瘤。
  • 需告知rEVAR患者3年再干预风险显著高于rOSR。

局限性

  • 单中心回顾性研究,样本量有限(88例破裂腹主动脉瘤)。
  • rEVAR超适应证使用可能限制结果外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of the study was to compare the cost-effectiveness of endovascular aortic repair (rEVAR) versus open surgical repair (rOSR) for ruptured abdominal aortic aneurysm (rAAA), where rEVAR is regularly performed outside of instructions for use (IFUs) (shorter and more angulated necks). Primary end point is incremental cost-effectiveness ratio (ICER) of rEVAR versus rOSR and aneurysm-related mortality. Secondary end points are cost per quality-adjusted life years (QALYs), perioperative morbidity and mortality, reintervention, and all-cause mortality. METHODS: All rAAA repairs performed between 2002 and 2016 in a single center were scrutinized. Between 2002 and 2007, most rAAAs were repaired using rOSR. From 2007 to 2016, we implemented a rEVAR with an anatomically possible protocol. During this time, severe angulation was rarely seen as a contraindication to rEVAR, and rEVAR was performed on aneurysms with an infrarenal aortic neck cranial to the aneurysm with a diameter of 20-33 mm and a length of at least 5 mm. Demographics and outcomes were reported according to the Society for Vascular Surgery guidelines. QALY was measured based on quality of time spent without symptoms of disease or toxicity of treatment (Q-TWiST) assessment. RESULTS: Eight hundred aneurysm surgeries were performed; of these, 135 were emergency surgeries of which 88 were for rAAA; (42 rEVARs and 46 rOSRs). Primary technical success (rEVAR 89.1% vs. rOSR 87.8%; P = 0.1), perioperative morbidity (rEVAR 56.5% vs. rOSR 64.3%; P = 0.457), and mortality (rEVAR 26.1% vs. rOSR 28.6%; P = 0.794) were nonsignificantly favorable in rEVAR patients. Freedom from reintervention was significantly lower in rEVAR patients at 3 years (rEVAR 74% vs. rOSR 90%; P = 0.038). Three-year aneurysm-related survival (rEVAR 65% vs. rOSR 62%; P = 0.848) and all-cause survival (rEVAR 56% vs. rOSR 51%; P = 0.577) were higher in rEVAR patients. At 3 years, rEVAR patients had a higher QALY of 1.671 versus OSR of 1.549 (P = 0.502). Operating room (P = 0.001) and total accommodation costs (P = 0.139) were lower in rEVAR patients, while equipment (P < 0.001), surveillance, and reintervention (P < 0.001) costs were higher. Median cost of rEVAR at 3 years was €23,352 vs. €20,494 for OSR (P < 0.084) (power>80%). Median cost per QALY of rEVAR at 3 years was €13,974 vs. €13,230 for rOSR (P = 0.296). ICER for rEVAR versus rOSR was €23,426 (95% confidence interval [CI] < €0 to > €30,000). At 3 years, the area under the curve and 95% CI for Q-TWiST was higher in rEVAR compared with OSR (rEVAR 500.819 vs. rOSR 437.838). CONCLUSIONS: There is no significant difference in cost or QALYs between rEVAR and rOSR even when rEVAR is performed on complex cases outside of IFU (shorter and more angulated necks). There is a significantly higher freedom from secondary intervention in rOSR patients compared with rEVAR patients at 3 years.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Canning P, Tawfick W, Kamel K, et al. Q-TWiST and Cost-Effectiveness Analysis of Endovascular versus Open Repair for Ruptured Abdominal Aortic Aneurysms in a High Deliberate Practice Volume Center. Ann Vasc Surg. 2018. PMID: 30476604. doi:10.1016/j.avsg.2018.08.091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。